DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

1.03
Delayed Data
As of Apr 20
 +0.03 / +3.00%
Today’s Change
0.78
Today|||52-Week Range
2.98
-5.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization3.9K5.1K5.6K5.6K
 
 
 
 
 
 
Operating ExpensesGross Income-3.9K-5.1K-5.6K-5.6K
 
 
 
 
 
General Expenses1.8M2.8M2.7M3.1M
 
 
 
 
 
Research And Development1.1M2.1M1.9M2.1M
 
 
 
 
 
Total Operating Expenses1.8M2.8M2.7M3.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.8M-2.8M-2.7M-3.2M
 
 
 
 
 
Extraordinary Credit0.00187.5K56.6K0.00
 
 
 
Extraordinary Charge-77.5K0.000.00-889.00
 
 
 
Other Expenses-6.9K6.4K-43.9K-7.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-2.6M-2.7M-3.2M
 
 
 
 
 
Preferred Dividend-209.8K-113.6K-41.7K-54.1K
 
 
 
 
 
Net Income-1.9M-2.6M-2.7M-3.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.6M13.6M15.3M22.6M
 
 
 
 
 
Shares To Calculate EPS Diluted11.6M13.6M15.3M22.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.20-$0.18-$0.14
 
 
 
 
 
EPS Diluted-$0.18-$0.20-$0.18-$0.14